BAM goes bust

Article

FileLink, a developer of storage management software, is out of business. The company, which began operations in 1997, closed its doors March 30, 2001, but plans to support existing customers for 60 days. Its core product, BAM, automates the migration of

FileLink, a developer of storage management software, is out of business. The company, which began operations in 1997, closed its doors March 30, 2001, but plans to support existing customers for 60 days. Its core product, BAM, automates the migration of digital assets across storage devices-hard disk drives, RAID systems, tape libraries, optical disk jukeboxes, outsourcing services, and off-line media. FileLink’s Medical Archive Software works with radiology information systems and diagnostic viewing stations to help hospitals manage clinical information. FileLink marketed its products primarily through distribution partners, software developers that embed BAM within applications, storage hardware suppliers, and system integrators. Partners included Alare, Aurora, Dynamic Healthcare, Data General, SwissRay, and Wam!Net.

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.